Zeke Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.01M | Sell |
6,972
-562
| -7% | -$162K | 0.13% | 72 |
|
|
2022
Q3 | $2.18M | Buy |
7,534
+5
| +0.1% | +$1.45K | 0.16% | 66 |
|
|
2022
Q2 | $2.12M | Sell |
7,529
-1,233
| -14% | -$347K | 0.14% | 71 |
|
|
2022
Q1 | $2.29M | Buy |
8,762
+1,322
| +18% | +$345K | 0.12% | 85 |
|
|
2021
Q4 | $1.63M | Buy |
7,440
+279
| +4% | +$61.3K | 0.1% | 69 |
|
|
2021
Q3 | $1.3M | Buy |
+7,161
| New | +$1.3M | 0.08% | 83 |
|
|
2020
Q1 | – | Sell |
-2,179
| Closed | -$477K | – | 503 |
|
|
2019
Q4 | $477K | Sell |
2,179
-13
| -0.6% | -$2.85K | 0.04% | 389 |
|
|
2019
Q3 | $371K | Sell |
2,192
-1,210
| -36% | -$205K | 0.03% | 413 |
|
|
2019
Q2 | $624K | Sell |
3,402
-24
| -0.7% | -$4.4K | 0.06% | 301 |
|
|
2019
Q1 | $630K | Buy |
3,426
+7
| +0.2% | +$1.29K | 0.06% | 310 |
|
|
2018
Q4 | $567K | Sell |
3,419
-132
| -4% | -$21.9K | 0.05% | 313 |
|
|
2018
Q3 | $684K | Sell |
3,551
-946
| -21% | -$182K | 0.06% | 324 |
|
|
2018
Q2 | $764K | Sell |
4,497
-53
| -1% | -$9K | 0.07% | 233 |
|
|
2018
Q1 | $742K | Buy |
4,550
+2,269
| +99% | +$370K | 0.07% | 254 |
|
|
2017
Q4 | $342K | Sell |
2,281
-720
| -24% | -$108K | 0.04% | 364 |
|
|
2017
Q3 | $456K | Buy |
3,001
+887
| +42% | +$135K | 0.06% | 242 |
|
|
2017
Q2 | $272K | Buy |
+2,114
| New | +$272K | 0.05% | 214 |
|